Novel biomarkers and uses thereof
Disclosed herein are novel biomarkers for identifying patients, with cancer, likely to benefit from treatment with an anti-CD25 agent. Also disclosed are methods using said biomarkers for making a treatment decision - or monitoring treatment with an anti-CD25 agent as well as methods of treating a p...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
16.01.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Disclosed herein are novel biomarkers for identifying patients, with cancer, likely to benefit from treatment with an anti-CD25 agent. Also disclosed are methods using said biomarkers for making a treatment decision - or monitoring treatment with an anti-CD25 agent as well as methods of treating a patient, with cancer, comprising administering an anti-CD25 agent based on prior use of the present biomarkers. |
---|---|
Bibliography: | Application Number: TW202211107231 |